Swedish Rhodiola Rosea Extract Effective In Treating Mild To Moderate Depression
A new clinical trial has found that an extract of Rhodiola rosea roots and rhizomes demonstrated anti-depressive activity in patients with mild to moderate depression.
This is the first double-blind, randomized, placebo-controlled study of Rhodiola rosea in patients diagnosed with depression. Patients given the Swedish-made Rhodiola rosea extract showed significant improvements in depression compared to those given placebo.
The authors concluded that SHR-5 demonstrates clear and significant anti-depressive activity in patients suffering from mild to moderate depression, evident from both overall depression levels as well as from specific symptom levels of depression. They further noted that no adverse effects could be detected in either of the groups given the Rhodiola rosea extract.